Welcome to the future of healthcare

DATA-DRIVEN. AI-ENABLED. HUMAN-CENTERED.

Featured Resources

01 / 03

Upcoming webinar

Multimodal Foundation Models in Action: Applications across Drug Development

Register now↗

Tempus Receives FDA Clearance for its ECG-MR AI Product Designed to Identify Undiagnosed Mitral Regurgitation

Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s RNA Foundation Model